Professor Park Ki-dong of Ajou University Selected as Fellow of the US Institute of Biomedical Engineering

Professor Park Ki-dong of the Department of Applied Chemical and Biological Engineering at Ajou University has been selected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

On the 28th, Ajou University announced that Professor Park was selected as a 2023 Fellow of AIMBE. He is recognized for his contributions to the advancement of nanotechnology and artificial organs through his research on polymer biomaterials, drug delivery systems, and tissue engineering.

AIMBE held an induction and welcome ceremony for the 140 Fellows of 2023, including Professor Park, on the 27th (local time) at its annual event in Arlington, Virginia, USA.

AIMBE is a non-profit organization composed of researchers from universities, industry, and government conducting top 2% global level research in medicine and biotechnology. Founded in 1991, it is headquartered in Washington, DC, USA.

Professor Ki-Dong Park, Department of Applied Chemical and Biological Engineering, Ajou University

Professor Park has developed various polymer biomaterials for disease diagnosis and treatment, including △ blood-compatible polymer biomaterials technology △ tissue-affinitive polymer materials △ polymer hydrogels for delivery of bioactive substances △ medical tissue adhesive materials △ drug delivery technologies △ regenerative medicine technologies.

He has also published 330 papers in prestigious domestic and international journals and registered and applied for 80 patents both in Korea and abroad. Through numerous technology transfers, he has contributed to the advancement of medical devices, pharmaceuticals, and the healthcare industry.

Furthermore, Professor Park has served as △ President of the Korean Society for Biomaterials △ Member of the Ministry of Health and Welfare Expert Committee △ Senior Expert Member of the National Research Foundation of Korea △ Vice President of the Polymer Society △ Member of the BK21+ Project Management Committee, and currently serves as the Co-Chair of the World Biomaterials Congress WBC2024 to be held in 2024 and Vice President of the Korean Society of Industrial Chemistry.

Professor Park expressed his thoughts, saying, “I am proud that South Korea’s biomaterials, drug delivery systems, and tissue engineering fields are at a world-class level, and I am very pleased that Ajou University is recognized as a global leading university in this field.”